{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-073335","form_type":"8-K","ticker":"TLSI","cik":"0001826667","company_name":"TriSalus Life Sciences, Inc.","filed_at":"2023-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.926160+00:00","generated_at":"2026-06-13T20:15:21.831439+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"MedTech Acquisition receives Nasdaq deficiency notice for MVLS below $35M minimum","bullets":["Nasdaq notified MTAC on June 14, 2023 of MVLS deficiency below $35M for 30 consecutive business days.","Company has 180 days (until Dec 11, 2023) to regain compliance by closing at $35M+ for 10 consecutive days.","No immediate impact on listing or trading; MTAC will monitor and consider available options."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-073335","json":"https://secwatch.observer/filing/0001104659-23-073335.json","markdown":"https://secwatch.observer/filing/0001104659-23-073335.md","text":"https://secwatch.observer/filing/0001104659-23-073335.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826667/000110465923073335/0001104659-23-073335-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826667/000110465923073335/tm2319190-1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T20:15:21.831439+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3a102db29b3d1354f8bc6b21dd69a2dca9e619b6","claim":"TriSalus Life Sciences, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).","evidence_excerpt":"June 14, 2023, MedTech Acquisition Corporation, a Delaware corporation (the “Company”), received a deficiency letter (the “Notice”) of non-compliance from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the preceding 30 consecutive business days, the Company’s Market Value of Listed Securities (“MVLS”) was below the $35 million minimum requirement for continued inclusion on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2) (the “MVLS Requirement”). The Notice has no immediate effect on the Company’s Na","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1826667/000110465923073335/0001104659-23-073335-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"market value"},{"label":"Rules","value":"5550(b)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}